JY
IMCR icon

Jeff Yass’s Immunocore IMCR Stock Holding History

Jeff Yass’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
+185,500
New +$5.49M ﹤0.01% 4295
2025
Q4 		– Sell
-68,300
Closed -$2.48M – 12934
2025
Q3 		$2.48M Sell
68,300
-206,700
-75% -$7.02M ﹤0.01% 5332
2025
Q2 		$8.63M Buy
275,000
+252,200
+1,106% +$7.83M ﹤0.01% 3041
2025
Q1 		$676K Buy
+22,800
New +$684K ﹤0.01% 8230
2024
Q4 		– Sell
-203,900
Closed -$6.35M – 12671
2024
Q3 		$6.35M Buy
+203,900
New +$7.42M ﹤0.01% 3218
2024
Q2 		– Sell
-26,600
Closed -$1.73M – 12599
2024
Q1 		$1.73M Buy
26,600
+3,600
+16% +$247K ﹤0.01% 5677
2023
Q4 		$1.57M Buy
+23,000
New +$1.2M ﹤0.01% 5885
2023
Q3 		– Sell
-44,000
Closed -$2.64M – 12444
2023
Q2 		$2.64M Sell
44,000
-7,300
-14% -$417K ﹤0.01% 4600
2023
Q1 		$2.54M Buy
51,300
+14,500
+39% +$815K ﹤0.01% 4651
2022
Q4 		$2.1M Sell
36,800
-67,600
-65% -$3.8M ﹤0.01% 4609
2022
Q3 		$4.9M Buy
104,400
+14,600
+16% +$696K ﹤0.01% 3182
2022
Q2 		$3.35M Buy
+89,800
New +$2.92M ﹤0.01% 3874

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jeff Yass's IMCR Position: Q2 2026 in Review

Jeff Yass increased its Immunocore (IMCR) stake by 296% in Q2 2026, buying an estimated $756K and bringing the position to 34,170 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #7995.

Jeff Yass first reported a position in IMCR in Q2 2022 and has held it in 11 quarters since. The position peaked at $3.49M in Q3 2024. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Jeff Yass held 34,170 shares of Immunocore worth $1.08M as of Q2 2026.
  • Jeff Yass bought 25,548 Immunocore shares in Q2 2026, an estimated $756K.
  • Immunocore made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7995 holding.
  • Jeff Yass first reported a position in Immunocore in Q2 2022 and has held it in 11 quarters since.
  • Jeff Yass's Immunocore position peaked at $3.49M in Q3 2024.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.